Back to Archived Journals » Gastrointestinal Cancer: Targets and Therapy

Gastrointestinal Cancer: Targets and Therapy ceased publishing in January 2020 All articles that have been published in Gastrointestinal Cancer: Targets and Therapy will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.

Gastrointestinal Cancer: Targets and Therapy


        

Journal Articles:

乐动体育西班牙人- 55 records -

Evidence for improvements to risk stratification in high-risk gastrointestinal stromal tumor patients

Greco A, Rossi S, Ruffolo C, Pauletti B, Dei Tos AP, Morana G, Massani M

Gastrointestinal Cancer: Targets and Therapy 2018, 8:25-36

Published Date: 3 December 2018

Emerging treatment options for BRAF-mutant colorectal cancer

乐动体育西班牙人Ursem C, Atreya CE, Van Loon K

Gastrointestinal Cancer: Targets and Therapy 2018, 8:13-23

Published Date: 22 March 2018

Models of intrahepatic cholangiocarcinoma: novel tools and therapeutic applications

乐动体育西班牙人Hill MA, Alexander WB, Hezel AF

Gastrointestinal Cancer: Targets and Therapy 2018, 8:1-11

Published Date: 19 February 2018

Efficacy of trastuzumab beyond progression as second-line chemotherapy for HER2-positive advanced gastric cancer

Sato Y, Yamashita H, Yagi K, Aikou S, Nishida M, Takenaka Y, Nomura S, Seto Y

Gastrointestinal Cancer: Targets and Therapy 2017, 7:39-45

Published Date: 1 December 2017

Gastric neuroendocrine tumors: management and challenges

Kwon DH, Nakakura EK, Bergsland EK, Dai SC

Gastrointestinal Cancer: Targets and Therapy 2017, 7:31-37

Published Date: 29 September 2017

Current perspectives on hyperthermic intraperitoneal chemotherapy in gastric cancer

乐动体育西班牙人Smith SD, Kirkpatrick D, Thomas P, Loggie BW

Gastrointestinal Cancer: Targets and Therapy 2017乐动体育西班牙人, 7:19-30

Published Date: 1 September 2017

Pancreatic cancer pain: impact and management challenges

Jones WB, Hale AL

Gastrointestinal Cancer: Targets and Therapy 2017乐动体育西班牙人, 7:13-17

Published Date: 24 May 2017

PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence

Tran PN, Sarkissian S, Chao J, Klempner SJ

Gastrointestinal Cancer: Targets and Therapy 2017, 7:1-11

Published Date: 5 May 2017

Therapeutic potential of mesenchymal stem cells in gastrointestinal cancers – current evidence

Qin J, Zhao Y, Wang Y, Betzler C, Popp FC, Sen Gupta A, Augsburger D, Camaj P, Nelson PJ, Bruns CJ

Gastrointestinal Cancer: Targets and Therapy 2016, 6:41-47

Published Date: 8 September 2016

Animal models of pancreatic cancer and their application in clinical research

乐动体育西班牙人Weidenhofer J, Colvin EK, Bond DR, Scarlett CJ

Gastrointestinal Cancer: Targets and Therapy 2016, 6:31-39

Published Date: 25 August 2016

Spotlight on bevacizumab in metastatic colorectal cancer: patient selection and perspectives

Bupathi M, Ahn DH, Bekaii-Saab T

Gastrointestinal Cancer: Targets and Therapy 2016乐动体育西班牙人, 6:21-30

Published Date: 30 June 2016

Pancreatic cancer vaccine: a unique potential therapy

Cappello P, Principe M, Novelli F

Gastrointestinal Cancer: Targets and Therapy 2016, 6:1-11

Published Date: 21 December 2015

The association between obesity and gastrointestinal cancer

乐动体育西班牙人Donohoe CL, Doyle SL, Reynolds JV

Gastrointestinal Cancer: Targets and Therapy 2015, 5:103-109

Published Date: 24 July 2015

Emerging role of microRNAs in the treatment of hepatocellular carcinoma

Callegari E, Domenicali M, Gramantieri L, Negrini M, Sabbioni S

Gastrointestinal Cancer: Targets and Therapy 2015, 5:89-102

Published Date: 14 May 2015

The potential of targeted antiangiogenesis therapies in the treatment of esophageal cancer

乐动体育西班牙人Xu WW, Li B, Cheung AL

Gastrointestinal Cancer: Targets and Therapy 2015, 5:79-88

Published Date: 29 April 2015

Ramucirumab: hitting another target in gastric cancer

Cohen MJ, Wainberg ZA

Gastrointestinal Cancer: Targets and Therapy 2015, 5:73-77

Published Date: 24 February 2015

Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss

Sendor AB, Hacker KE, Chen S, Corona AL, Sen O, Chiang DY, Snavely A, Rogers AB, Montgomery SA, Rathmell WK, McRee AJ

Gastrointestinal Cancer: Targets and Therapy 2015乐动体育西班牙人, 5:61-71

Published Date: 24 February 2015

Prospective prediction of resistance to neoadjuvant therapy in patients with locoregional esophageal adenocarcinoma

乐动体育西班牙人Rosen DG, Shan W, Lassen N, Johnson C, Oelschlager K, Bierman-Harrar Y, Kesler KA, Maetzold D, Badve S, Cook RW, Saxena R

Gastrointestinal Cancer: Targets and Therapy 2015乐动体育西班牙人, 5:53-59

Published Date: 19 February 2015

EGFR signaling in colorectal cancer: a clinical perspective

Saletti P, Molinari F, De Dosso S, Frattini M

Gastrointestinal Cancer: Targets and Therapy 2015乐动体育西班牙人, 5:21-38

Published Date: 19 January 2015

Nanoparticle albumin-bound (nab)-paclitaxel for the treatment of pancreas ductal adenocarcinoma

Narayanan V, Weekes CD

Gastrointestinal Cancer: Targets and Therapy 2015乐动体育西班牙人, 5:11-19

Published Date: 6 January 2015

Targeting cancer stem cells in hepatocellular carcinoma

He AR, Smith DC, Mishra L

Gastrointestinal Cancer: Targets and Therapy 2015, 5:1-10

Published Date: 17 December 2014

Esophageal cancer-related gene 4 at the interface of injury, inflammation, infection, and malignancy

Baird A, Lee J, Podvin S, Kurabi A, Dang X, Coimbra R, Costantini T, Bansal V, Eliceiri BP

Gastrointestinal Cancer: Targets and Therapy 2014乐动体育西班牙人, 4:131-142

Published Date: 24 October 2014

Targeting cancer stem cells in gastric cancer

乐动体育西班牙人Ishimoto T, Baba H

Gastrointestinal Cancer: Targets and Therapy 2014乐动体育西班牙人, 4:123-129

Published Date: 15 October 2014

STAT3 as an emerging molecular target in pancreatic cancer

Sharma NK, Shankar S, Srivastava RK

Gastrointestinal Cancer: Targets and Therapy 2014, 4:115-122

Published Date: 25 August 2014

Pathology, genetic alterations, and targets of differentially expressed microRNAs in pancreatic cancer

乐动体育西班牙人Azevedo-Pouly ACP, Schmittgen TD

Gastrointestinal Cancer: Targets and Therapy 2014, 4:75-87

Published Date: 18 June 2014

Critical analysis of the potential for therapeutic targeting of mammalian target of rapamycin (mTOR) in gastric cancer

Inokuchi M, Kato K, Kojima K, Sugihara K

Gastrointestinal Cancer: Targets and Therapy 2014乐动体育西班牙人, 4:39-48

Published Date: 8 April 2014

Assessing the role of the EGF receptor in the development and progression of pancreatic cancer

Cook N, Frese KK, Moore M

Gastrointestinal Cancer: Targets and Therapy 2014乐动体育西班牙人, 4:23-37

Published Date: 2 April 2014

Targeting HER2 amplifications in gastric cancer

乐动体育西班牙人Ung L, Chua TC, Merrett ND

Gastrointestinal Cancer: Targets and Therapy 2014, 4:11-22

Published Date: 31 January 2014

Warty gastric cancer with polypoid metastases to the gallbladder and urinary bladder

Matsuyama M, Kato K, Goto S, Moritani S, Sentani K, Kuroda M

Gastrointestinal Cancer: Targets and Therapy 2013, 3:35-37

Published Date: 9 September 2013

Adjuvant therapy of pancreatic carcinoma: the experience of Policlinico Umberto I, Università "Sapienza" Rome

De Felice F, Musio D, Cassese R, Masi D, Tombolini V

Gastrointestinal Cancer: Targets and Therapy 2013, 3:29-33

Published Date: 12 August 2013

Anal cancer: current and future treatment strategies

乐动体育西班牙人Chin JY, Hong TS, Wo JY

Gastrointestinal Cancer: Targets and Therapy 2013乐动体育西班牙人, 3:19-27

Published Date: 17 January 2013

Treatment of squamous cell and adenocarcinoma of the esophagus

Rathbone B, Jankowski J, Rathbone M

Gastrointestinal Cancer: Targets and Therapy 2012, 2:39-49

Published Date: 13 November 2012

Precursors to invasive pancreatic cancer

Smith JA, Singhi AD, Maitra A

Gastrointestinal Cancer: Targets and Therapy 2012, 2:19-27

Published Date: 27 August 2012

Application of miRNA expression analysis on exfoliated colonocytes for diagnosis of colorectal cancer

Murata S, Koga Y, Moriya Y, Akasu T, Fujita S, Yamamoto S, Kakugawa Y, Ohtake Y, Saito N, Matsumura Y

Gastrointestinal Cancer: Targets and Therapy 2012乐动体育西班牙人, 2:11-18

Published Date: 4 May 2012

A new method of endoscopic ultrasonography for determining lesion depth in early gastric cancer

Mitsunaga A, Tagata T, Hamano T, Teramoto H, Shirato I, Shirato M, Nishino T

Gastrointestinal Cancer: Targets and Therapy 2012, 2:1-10

Published Date: 29 December 2011

The role of S-1 in the treatment of gastric cancer

乐动体育西班牙人Blum MA, Suzuki A, Taketa T, Ajani J

Gastrointestinal Cancer: Targets and Therapy 2011乐动体育西班牙人, 1:59-67

Published Date: 16 December 2011

Role of sunitinib for the management of pancreatic neuroendocrine tumors

乐动体育西班牙人Reidy-Lagunes DL, Wyluda EEW

Gastrointestinal Cancer: Targets and Therapy 2011乐动体育西班牙人, 1:53-57

Published Date: 15 August 2011

Targeting HER-2 in gastric cancer – incorporation of trastuzumab into the treatment of operable disease

乐动体育西班牙人Bystricky B, Okines AFC, Cunningham D

Gastrointestinal Cancer: Targets and Therapy 2011乐动体育西班牙人, 1:41-52

Published Date: 18 July 2011

The diagnostic and prognostic role of cytokines in colon cancer

乐动体育西班牙人Long T, Raufman JP

Gastrointestinal Cancer: Targets and Therapy 2011, 1:27-39

Published Date: 26 April 2011

Hereditary diffuse gastric cancer: genetics, prophylactic total gastrectomy, and follow up

Shenoy S, Palmer C, Dunsworth T, McNatt S

Gastrointestinal Cancer: Targets and Therapy 2011乐动体育西班牙人, 1:15-19

Published Date: 18 April 2011

Trends in incidence of gallbladder cancer – Indian scenario

乐动体育西班牙人Nandagudi Srinivasa Murthy, Dinesh Rajaram, MS Gautham, et al

Gastrointestinal Cancer: Targets and Therapy 2011, 1:1-9

Published Date: 28 January 2011